La Cañada Flintridge, CA, United States of America

Frances H Arnold

This inventor holds 71 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Enzyme Engineering (CPC class C12P). Top assignees: California Institute of Technology, Gevo, Inc., The United States of America as Represented by the Department of Energy. Active years: 1994-2025. National Inventors Hall of Fame inductee. Nobel Prize laureate.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frances H Arnold. Retrieved from https://idiyas.com/inventor/frances-h-arnold

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 71 (Patent Applications = 12)

% Patents Active = 87.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 3.1

ph-index = 17

Forward Citations = 1,837(Granted Patents)

Forward Citations (Not Self Cited) = 1,606(Dec 10, 2025)

Inventors with similar research interests:

Location History:

La Cañada, CA (US) (2009 - 2015)
La Canada, CA (US) (2007 - 2021)
Pasadena, CA (US) (1994 - 2022)
La Canada Flintridge, CA (US) (2024)

Company Filing History:

68 out of 4,632

California Institute of Technology

The United States of America as Represented by the Department of Energy

patents

4. 1 out of 490

Dow Silicones Corporation

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

Areas of Expertise:

Enzyme Engineering

Cytochrome P450

Alkane Oxidation

Organosilicon Products

Chimeric Cellobiohydrolases

Sulfimidation

Olefin Cyclopropanation

Modified Hydroxylases

Thermostability

Carbohydrates

Alcohol Dehydrogenases

Engineered Microorganisms

71 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421534 - Engineered enzymes and method for the synthesis of diverse tyrosine analogs (2025-09-23),

2. 12258605 - Alkane oxidation by modified hydroxylases (2025-03-25),

3. 12227529 - Method of preparing silanols with selective cytochrome P450 variants and related compounds and compositions (2025-02-18),

4. 11858969 - Engineered light-sensitive proteins (2024-01-02),

5. 11214817 - Alkane oxidation by modified hydroxylases (2022-01-04),

6. 11008596 - Cytochrome P450 BM3 enzyme variants for preparation of cyclopropanes (2021-05-18),

7. 10934531 - Method for enantioselective carbene C—H insertion using an iron-containing protein catalyst (2021-03-02),

8. 10927355 - Method for producing an organosilicon product (2021-02-23),

9. 10648006 - Alkane oxidation by modified hydroxylases (2020-05-12),

10. 10501762 - Methods and systems for sulfimidation or sulfoximidation of organic molecules (2019-12-10),

11. 10208322 - In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes (2019-02-19),

12. 10093906 - Cytochrome C protein variants for catalyzing carbon-silicon bond formation (2018-10-09),

13. 9963720 - Alkane oxidation by modified hydroxylases (2018-05-08),

14. 9708633 - Stable, functional chimeric cellobiohydrolase class I enzymes (2017-07-18),

15. 9493799 - In vivo and in vitro olefin cyclopropanation catalyzed by heme enzymes (2016-11-15),

Title: The Pioneering Work of Inventor Frances H Arnold

Introduction

Frances H Arnold, a distinguished inventor hailing from La Canada, CA, has made significant contributions to the field of biotechnology and molecular engineering. Her innovative work has led to the development of numerous patented technologies, shaping the landscape of modern science.

Latest Patents

Arnold's latest patents showcase her expertise in engineering light-sensitive proteins and advancing alkane oxidation processes. She has revolutionized the field with inventions such as engineered channelrhodopsins for neuronal circuit interrogation and modified hydroxylases for producing hydroxylated alkanes efficiently.

Career Highlights

Throughout her career, Frances H Arnold has been associated with prestigious institutions such as the California Institute of Technology and Gevo, Inc. Her groundbreaking research has paved the way for novel applications in the treatment of neuronal and ocular disorders, demonstrating her commitment to driving innovation in biotechnology.

Collaborations

Arnold's collaborations with esteemed colleagues like Peter Meinhold and Matthew W Peters have been instrumental in her success. Together, they have worked on cutting-edge projects that have garnered international recognition and reshaped the boundaries of scientific exploration.

Conclusion

In conclusion, Frances H Arnold stands as a trailblazer in the field of molecular engineering, with 68 patents to her name. Her ingenuity and dedication to pushing the boundaries of science highlight her as a prominent figure in the realm of biotechnology. The impact of her work reverberates across industries, shaping the future of innovation and technology.

Profile summary based on public USPTO records.